In these brain tumors miR-181a was shown to target the anti-apoptotic genes BCL2 and MCL1, and downregulated miR-181a reduced glucose deprivation-induced apoptosis and caused mitochondrial dysfunction in astrocytes [22, 49, 50]. The gene discussed is MCL1; the disease is brain neoplasm.